scholarly journals Ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma: a systematic review and clinical practice guideline

2007 ◽  
Vol 14 (4) ◽  
pp. 144-148 ◽  
Author(s):  
Denise Stys-Norman
Keyword(s):  
Systematic Review ◽  
Clinical Practice ◽  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Combination Chemotherapy ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Advanced Soft Tissue Sarcoma

scholarly journals Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline

2013 ◽  
Vol 20 (3) ◽  
pp. 247 ◽  
Author(s):  
R. Kandel ◽  
N. Coakley ◽  
J. Werier ◽  
J. Engel ◽  
M. Ghert ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Surgical Margins

Nonpharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline

2017 ◽  
Vol 166 (7) ◽  
pp. 493 ◽  
Author(s):  
Roger Chou ◽  
Richard Deyo ◽  
Janna Friedly ◽  
Andrea Skelly ◽  
Robin Hashimoto ◽  
...  
Keyword(s):  
Systematic Review ◽  
Low Back Pain ◽  
Back Pain ◽  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Low Back

scholarly journals Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients

2020 ◽  
Vol 38 (27) ◽  
pp. 3205-3216
Author(s):  
Thomas Lehrnbecher ◽  
Brian T. Fisher ◽  
Bob Phillips ◽  
Melissa Beauchemin ◽  
Fabianne Carlesse ◽  
...  
Keyword(s):  
Systematic Review ◽  
Stem Cell ◽  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Pediatric Patients ◽  
Antifungal Prophylaxis ◽  
Hematopoietic Stem ◽  
Strong Recommendation ◽  
Patients With Cancer

PURPOSE To develop a clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation (HSCT) recipients. METHODS Recommendations were developed by an international multidisciplinary panel that included a patient advocate. We conducted a systematic review of systemic antifungal prophylaxis in children and adults with cancer and HSCT recipients. The Grading of Recommendations Assessment, Development, and Evaluation approach was used to make strong or weak recommendations and to classify level of evidence as high, moderate, low, or very low. The panel considered directness of the data to pediatric patients. RESULTS There were 68 randomized trials included in the systematic review, of which 6 (9%) were conducted in a solely pediatric population. Strong recommendations were made to administer systemic antifungal prophylaxis to children and adolescents receiving treatment of acute myeloid leukemia, to those undergoing allogeneic HSCT pre-engraftment, and to those receiving systemic immunosuppression for graft-versus-host disease treatment. A strong recommendation was made to administer a mold-active agent with an echinocandin or a mold-active azole when systemic antifungal prophylaxis is warranted. For children younger than 13 years of age, an echinocandin, voriconazole, or itraconazole is suggested. Posaconazole may also be used in those age 13 years or older. A strong recommendation against routine administration of amphotericin as systemic antifungal prophylaxis was made. CONCLUSION We developed a clinical practice guideline for systemic antifungal prophylaxis administration in pediatric patients with cancer and HSCT recipients. Implementation and assessment of guideline-concordant rates and impacts are important future steps.

Sign in / Sign up

Export Citation Format

Share Document